Natural selection for rash-forming genotypes of the varicella-zooster vaccine virus detected within immunized human hosts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 1, 2007, Pages 208-212

  Quinlivan, Mark L ^a   Gershon, Anne A ^b   Al Bassam, Mahmoud M ^a   Steinberg, Sharon P ^b   LaRussa, Philip ^b   Nichols, Richard A ^c   Breuer, Judith ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Black Building 4 427 ^*  (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chickenpox; Epidemiology; IE62; Shingles; Virulence

Indexed keywords

PROTEIN IE62; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHICKENPOX; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EUROPE; GENOTYPE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INOCULATION; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; RASH; UNITED STATES; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS VIRULENCE;

CHICKENPOX VACCINE; EXANTHEMA; GENE FREQUENCY; GENOTYPE; HERPESVIRUS 3, HUMAN; HUMANS; OPEN READING FRAMES; SELECTION (GENETICS); VACCINATION;

EID: 33846117844     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0605688104     Document Type: Article

References (26)

1. Holmes SJ, Reef S, Hadler SC, Williams WW, Wharton M (1996) MMAR 45:RR-11.
2. Rentier B, Gershon AA (2004) Pediatr Infect Dis J 23:379-389.
3. Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA (2000) Vaccine 19:916-923.
4. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM (1998) J Virol 72:965-974.
5. Arvin AM (2001) Curr Opin Microbiol 4:442-449.
6. Chen JJ, Gershon AA, Li ZS, Lungu O, Gershon MD (2003) J Med Virol 70:871-78.
7. Hardy I, Gershon AA, Steinberg SP, LaRussa P (1991) N Engl J Med 325:1545-1550.
8. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K (2002) J Virol 76:11447-11459.
9. Quinlivan ML, Gershon AA, Nichols RA, LaRussa P, Steinberg SP, Breuer J (2006) J Infect Dis 193:927-930.
10. Gomi Y, Imagawa T, Takahashi M, Yamanishi K (2000) J Med Virol 61:497-503.
11. Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A (1975) Biken J 18:25-33.
12. Quinlivan ML, Gershon AA, Steinberg SP, Breuer J (2004) J Infect Dis 190:793-796.
13. Westrop GD, Wareham KA, Evans DM, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC (1989) J Virol 63:1338-1344.
14. Mattocks C, Tarpey P, Bobrow M, Whittaker J (2000) Hum Mutat 16:437-443.
15. Qiu P, Soder GJ, Sanfiorenzo VJ, Wang L, Greene JR, Fritz MA, Cai XY (2003) Biochem Biophys Res Commun 309:331-338.
16. Shiraki K, Yoshida Y, Asano Y, Yamanishi K, Takahashi M (2003) J Infect Dis 188:875-877.
17. Cohrs RJ, Gilden DH, Gomi Y, Yamanishi K, Cohen JI (2006) J Virol 80:2076-2082.
18. Sato B, Ito H, Hinchliffe S, Sommer MH, Zerboni L, Arvin AM (2003) J Virol 77:5607-5620.
19. Sommer MH, Zagha E, Serrano OK, Ku CC, Zerboni L, Baiker A, Santos R, Spengler M, Lynch J, Grose C, et al (2001) J Virol 75:8224-8239.
20. Lynch JM, Kenyon TK, Grose C, Hay J, Ruyechan WT (2002) Virology 302:71-82.
21. Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM (2003) J Infect Dis 188:40-52.
22. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) Immunogenetics 50:213-219.
23. Cherkasova EA, Korotkova EA, Yakovenko ML, Ivanova OE, Eremeeva TP, Chumakov KM, Agol VI (2002) J Virol 76:6791-6799.
24. Kramer JM, LaRussa P, Tsai WC, Carney P, Leber SM, Gahagan S, Steinberg S, Blackwood RA (2001) Pediatrics 108:E39.
25. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR (2003) J Infect Dis 188:954-959.
26. Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, Wilson SB, Shaulov A, Fleisher G, Geha RS (2003) J Infect Dis 188:948-953.